UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses
UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses
UnitedHealth Hits 15‑Month High: Congressional Trades That Suddenly Look Brilliant
10 Information Technology Stocks Whale Activity In Today’s Session
IBM shares are trading higher after Argus Research maintained its Buy rating on the stock and lowered its price target from $360 to $280. Also, Evercore ISI Group maintained its Ou…
Baird Upgrades UnitedHealth Group to Neutral, Raises Price Target to $453
B of A Securities Maintains Buy on Goldman Sachs Group, Raises Price Target to $1300
B of A Securities Maintains Buy on JPMorgan Chase, Raises Price Target to $420
UBS Maintains Buy on Coca-Cola, Raises Price Target to $98
Shares of consumer staples companies are trading higher as investors rotate into defensive sectors amid recent market volatility and heightened uncertainty. Investors may be drawn …
Raymond James Maintains Outperform on Johnson & Johnson, Raises Price Target to $265
Korea Drives Semi Stocks Lower Despite Solid Taiwan Semi Earnings; Apple Boosts China AI Models
Stock of the Day: Is This the Bottom for IBM?
'Verizon to Cut About 3,000 Jobs, Divest Itself of Some Retail Stores' - Wall Street Journal
FDA Approval Adds New Cholesterol Treatment Option in Merck Portfolio
What's Going on With Nike Stock Thursday?
QUICK SPARK: TSMC's Worst Selloff Since 2022 Looks Bad — Until You Look At Intel
JP Morgan Maintains Overweight on Procter & Gamble, Lowers Price Target to $162
Coca-Cola's fairlife Hit By Ransomware Attack, Temporarily Suspends U.S. Production; Product Quality And Safety Have Not Been Impacted
Citigroup Maintains Neutral on Goldman Sachs Group, Raises Price Target to $1200
Manulife Adds High-Conviction Large-Cap ETF to Capitalize on Momentum